Pipeline

Candidate & Indication Development Stage
Discovery Preclinical Phase 1 Phase 2 Phase 3 Review
SHP622 (Licensed to Shire Plc) Friedreich's Ataxia & Other Neurodegenerative Disorders
Discovery Phase complete
Preclinical Phase complete
Phase 1 Phase in progress
Phase 2 Phase not started
Phase 3 Phase not started
Review Phase not started
Anti-TAUC3 Monoclonal Antibody Progressive Supranuclear Palsy, Traumatic Brain Injury & Other Tauopathies
Discovery Phase complete
Preclinical Phase in progress
Phase 1 Phase not started
Phase 2 Phase not started
Phase 3 Phase not started
Review Phase not started